Patient Advocates - The Flour In The Cake

As my Mom continues to suffer the side effects of a fluoroquinolone drug, I am more convinced than ever of the importance of patient advocates, especially for the elderly. Mom has Lymphoma, the bad kind, but her symptoms today - confusion, anxiety, and disorientation are not related to her underlying disease or her age. I know the symptoms all to well, the nasty side effects of fluoroquinolones, as I too was “floxed“.

Mom has always been independent and competent, making her own medical, financial, and life decisions. Today she is scared, needs someone to help her navigate through this broken medical system and make decisions for her. I can vividly remember feeling the same way when I was “floxed” years ago. Although it took me more than a year to recover, I had youth in my favor and was not suffering from cancer.

Yesterday was mom’s scheduled treatment day. The doctor decided she was too run down to risk receiving treatment. I keep wondering if it’s not the Avelox preventing her from receiving the treatment she needs. I can’t tell you how anxious I was to get at those doctors and hear their justification for prescribing a restricted, last-resort antibiotic, contraindicated for the elderly, and intended for treatment of confirmed bacterial infections that have not responded to other treatment. THIS is the drug they gave my mom for her cold symptoms.

The nurse chose to argue with me, but I would have none of it. I INSISTED that Mom’s records instruct that she is NEVER to be prescribed any fluoroquinolones. The nurse asked, “How about Cipro (another fluoroquinilone)?” I’m like, “What part of NO fluoroquinolones do you not understand!?” She continued to try and sell me on fluoroquinolones, when the doctor came in. Lucky for him, he agreed with me, and Mom’s records now show that she has an allergy to fluoroquinolones.

Patient advocacy has gone from being the frosting on the medical care cake to being a necessary ingredient in any recipe for medical care that does more harm than good. Patients have to be informed, but all the information in the world still doesn’t help if you (or your advocate) doesn’t have the tenacity to insist that your views, concerns, and wishes be acknowledged, with or without the MD behind your name. This is especially critical for the elderly, who often do not have the resilience to recover from medical mistakes or sloppy drug-pushing.

What has happened to our medical system? Once upon a time, there was a deep bond of trust between doctors and patients, back when we didn’t need to be a walking pharmaceutical encyclopedia to understand our medical care. What if we didn’t have the internet? Would we (the patients and patient advocates) be better or worse off? How do you think your doctor would answer that question? Are you willing to rely on information that you receive from your doctor, or do you feel the need to research and direct your own care?

Susan Beausang, 4Women.com

Blog Category: 

More Articles

More Articles

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

In a large trial of older, newly diagnosed patients with chronic lymphocytic leukemia (CLL),...

Today’s typical treatments have been unable to cure numerous types of lymphoma, but emerging immunotherapies could provide the key to...

Biotech firm Gilead Sciences Inc. has announced that the first patient has been dosed in a Phase III trial evaluating the safety and efficacy of...

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta, researchers out of MD Anderson Cancer Center in...

The results of a pair of long-term survival studies indicate the therapeutic value of BEXXAR (...

A new lab test that can improve survival rates among patients with chronic lymphocytic leukemia (...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Sitemap